Similar articles for PMID: 29150406

Year	Number of Results
1946	1
1947	1
1948	3
1949	1
1950	1
1951	4
1953	1
1954	4
1955	1
1956	4
1958	2
1960	2
1962	1
1963	5
1964	4
1965	2
1969	1
1978	1
1979	1
1990	1
1991	2
1992	2
1994	1
1996	3
1997	1
1998	4
1999	1
2001	1
2003	3
2004	1
2005	2
2006	1
2008	1
2009	1
2012	3
2013	1
2014	7
2015	4
2016	6
2017	5
2018	7
2019	4
2022	1
2024	0

1

Towards patient-centred and cost-effective care for patients with cirrhosis and ascites.

Thomson M, Tapper EB. Thomson M, et al. Lancet Gastroenterol Hepatol. 2018 Feb;3(2):75-76. doi: 10.1016/S2468-1253(17)30339-4. Epub 2017 Nov 15. Lancet Gastroenterol Hepatol. 2018. PMID: 29150406 Free PMC article. No abstract available.

2

The benefit of paracentesis on hospitalized adults with cirrhosis and ascites.

Gaetano JN, Micic D, Aronsohn A, Reddy G, Te H, Reau NS, Jensen D. Gaetano JN, et al. J Gastroenterol Hepatol. 2016 May;31(5):1025-30. doi: 10.1111/jgh.13255. J Gastroenterol Hepatol. 2016. PMID: 26642977

3

A cost analysis of long term antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhosis.

Das A. Das A. Am J Gastroenterol. 1998 Oct;93(10):1895-900. doi: 10.1111/j.1572-0241.1998.00545.x. Am J Gastroenterol. 1998. PMID: 9772051

4

Cost Effectiveness of Early Insertion of Transjugular Intrahepatic Portosystemic Shunts for Recurrent Ascites.

Shen NT, Schneider Y, Congly SE, Rosenblatt RE, Namn Y, Fortune BE, Jesudian A, Brown RS Jr. Shen NT, et al. Clin Gastroenterol Hepatol. 2018 Sep;16(9):1503-1510.e3. doi: 10.1016/j.cgh.2018.03.027. Epub 2018 Mar 30. Clin Gastroenterol Hepatol. 2018. PMID: 29609068

5

Details Make the Difference: The Important Need to Accurately Understand the Cost-Effectiveness of Transjugular Intrahepatic Portosystemic Shunts in Patients with Ascites.

Shen NT, Brown RS Jr, Fortune BE. Shen NT, et al. J Vasc Interv Radiol. 2019 Aug;30(8):1310-1311. doi: 10.1016/j.jvir.2019.01.021. Epub 2019 May 3. J Vasc Interv Radiol. 2019. PMID: 31060771 No abstract available.

6

Reply to: "Details Make the Difference: The Important Need to Accurately Understand the Cost-Effectiveness of Transjugular Intrahepatic Portosystemic Shunts in Patients with Ascites".

Kwan SW; authors. Kwan SW, et al. J Vasc Interv Radiol. 2019 Aug;30(8):1311-1312. doi: 10.1016/j.jvir.2019.04.018. J Vasc Interv Radiol. 2019. PMID: 31349980 No abstract available.

7

Cost-Effectiveness of Transjugular Intrahepatic Portosystemic Shunt versus Large-Volume Paracentesis in Refractory Ascites: Results of a Markov Model Incorporating Individual Patient-Level Meta-Analysis and Nationally Representative Cost Data.

Kwan SW, Allison SK, Gold LS, Shin DS. Kwan SW, et al. J Vasc Interv Radiol. 2018 Dec;29(12):1705-1712. doi: 10.1016/j.jvir.2018.08.019. Epub 2018 Nov 2. J Vasc Interv Radiol. 2018. PMID: 30392803 Free PMC article.

8

Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites.

Di Pascoli M, Fasolato S, Piano S, Bolognesi M, Angeli P. Di Pascoli M, et al. Liver Int. 2019 Jan;39(1):98-105. doi: 10.1111/liv.13968. Epub 2018 Oct 8. Liver Int. 2019. PMID: 30230204

9

[Cancer antigen 125 as a marker of ascites in patients with liver cirrhosis].

Jabłkowski M, Białkowska J, Koktysz R, Bartkowiak J, Stankiewicz W, Dworniak D. Jabłkowski M, et al. Pol Merkur Lekarski. 2004;17 Suppl 1:149-52. Pol Merkur Lekarski. 2004. PMID: 15603376 Polish.

10

Hemodialysis alternative with ascites ultrafiltration for an end-stage renal failure patient associated with tense ascites secondary to decompensated liver cirrhosis.

Hwang JC, Chen JA, Fung HY. Hwang JC, et al. Am J Kidney Dis. 1996 Dec;28(6):899-903. doi: 10.1016/s0272-6386(96)90391-1. Am J Kidney Dis. 1996. PMID: 8957043

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

97 results

Results by year